Literature DB >> 15026153

Melanocortin 4 receptor is expressed in the dorsal root ganglions and down-regulated in neuropathic rats.

Katarzyna Starowicz1, Wiktor Bilecki, Agnieszka Sieja, Barbara Przewlocka, Ryszard Przewlocki.   

Abstract

Recent reports have demonstrated effectiveness of melanocortin antagonists as potent analgesics, and have suggested that the spinal melanocortin 4 receptor (MC4-R) mediates their effects on pain transmission. These findings prompted us to investigate the changes in MC4-R mRNA level in the spinal cord and dorsal root ganglia (DRG) of neuropathic animals at different time points after sciatic nerve injury by quantitative real-time PCR. The spinal MC4-R mRNA level was not affected by sciatic nerve injury. In contrast, down-regulation of MC4-R mRNA in DRG developed 2 weeks after the injury and was parallel with the attenuated effectiveness of MC4-R ligands in neuropathic animals. The MC4-R adaptation in DRG observed in neuropathic rats indicates their important role in presynaptic modulation of activity of the primary afferents in neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026153     DOI: 10.1016/j.neulet.2003.12.096

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Approaches to the rational design of selective melanocortin receptor antagonists.

Authors:  Victor J Hruby; Minying Cai; Joel Nyberg; Dhanasekaran Muthu
Journal:  Expert Opin Drug Discov       Date:  2011-03-24       Impact factor: 6.098

2.  Melanocortin-4 receptor expression in different classes of spinal and vagal primary afferent neurons in the mouse.

Authors:  Laurent Gautron; Charlotte E Lee; Syann Lee; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2012-12-01       Impact factor: 3.215

Review 3.  Synaptic changes induced by melanocortin signalling.

Authors:  Vanni Caruso; Malin C Lagerström; Pawel K Olszewski; Robert Fredriksson; Helgi B Schiöth
Journal:  Nat Rev Neurosci       Date:  2014-02       Impact factor: 34.870

4.  Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1.

Authors:  Rasmus Eliasen; Norelle L Daly; Birgitte S Wulff; Thomas L Andresen; Kilian W Conde-Frieboes; David J Craik
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

5.  Melanocortin-4 receptor signaling in the central amygdala mediates chronic inflammatory pain effects on nociception.

Authors:  Nathan M Sharfman; Leslie K Kelley; Maria E Secci; Nicholas W Gilpin
Journal:  Neuropharmacology       Date:  2022-03-16       Impact factor: 5.273

6.  Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin.

Authors:  Ada Delaney; Margaret Keighren; Susan M Fleetwood-Walker; Ian J Jackson
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

7.  Opioid and melanocortin receptors: do they have overlapping pharmacophores?

Authors:  Yeon Sun Lee; Richard S Agnes; James P Cain; Vinod Kulkarni; Minying Cai; Christine Salibay; Kathy Ciano; Ravil Petrov; Alexander Mayorov; Josef Vagner; Dev Trivedi; Peg Davis; Shou-wu Ma; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  Biopolymers       Date:  2008       Impact factor: 2.505

8.  Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptors.

Authors:  H S Sharma; A Skottner; T Lundstedt; M Flärdh; L Wiklund
Journal:  J Neural Transm (Vienna)       Date:  2006-04       Impact factor: 3.575

9.  Comparative in Vivo Investigation of Intrathecal and Intracerebroventricular Administration with Melanocortin Ligands MTII and AGRP into Mice.

Authors:  Danielle N Adank; Mary M Lunzer; Cody J Lensing; Stacey L Wilber; Amy M Gancarz; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2017-10-19       Impact factor: 4.418

10.  Influence of clonidine and ketamine on m-RNA expression in a model of opioid-induced hyperalgesia in mice.

Authors:  Henning Ohnesorge; Zhiying Feng; Karina Zitta; Markus Steinfath; Martin Albrecht; Berthold Bein
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.